Literature DB >> 6130456

Tracheal relaxant and cardiostimulant actions of xanthines can be differentiated from diuretic and CNS-stimulant effects. Role of adenosine antagonism?

C G Persson, I Erjefält, L E Edholm, J A Karlsson, C J Lamm.   

Abstract

Theophylline (1, 3-dimethylxanthine) and enprofylline (3-propylxanthine) have been examined for effects in the rat. Enprofylline was 3.8 times as potent as theophylline as a tracheal relaxant in vitro, and 1.3 times as potent as theophylline to increase the rate of isolated perfused hearts. An oral dose (5 mg/kg) of enprofylline to rats was almost completely recovered in the urine as unchanged drug, showing that this xanthine is well absorbed and negligibly metabolised. Theophylline (10 and 30 mg/kg p.o.) significantly and dose-dependently increased locomotor activity in rats whereas the same doses of enprofylline were without effect on behaviour. Theophylline ( 5-20 mg/kg p.o.) produced significant and dose-dependent natriuretic and volume diuretic effect with little augmentation of potassium excretion. Enprofylline up to 10 mg/kg was without diuretic effects. At the large dose of 20 mg/kg enprofylline decreased sodium excretion and produced some volume diuresis. It is suggested that lack of diuretic and CNS-stimulant behavioural effects by enprofylline is due to its low ability to antagonise adenosine receptor stimulation. Pharmacodynamic differences between enprofylline and the potent adenosine antagonist theophylline may indicate a functional importance of endogenous adenosine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130456     DOI: 10.1016/0024-3205(82)90711-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Protein binding of enprofylline.

Authors:  K Tegnér; O Borgå; I Svensson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Enprofylline pharmacokinetics in children with asthma.

Authors:  C Hultqvist; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist.

Authors:  R J Knight; C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

4.  Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism.

Authors:  K E Andersson; N Johannesson; B Karlberg; C G Persson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose.

Authors:  E Lunell; O Borgå; R Larsson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Comparison of oral enprofylline and theophylline in asthmatic patients.

Authors:  L C Laursen; N Johannesson; I Søndergaard; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Effect of theophylline and enprofylline on bronchial hyperresponsiveness.

Authors:  G H Koëter; J Kraan; M Boorsma; J H Jonkman; T W van der Mark
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

8.  Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation.

Authors:  M J Finney; J A Karlsson; C G Persson
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

9.  Effects of probenecid on enprofylline kinetics in man.

Authors:  O Borgå; R Larsson; E Lunell
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Absorption of enprofylline from the gastrointestinal tract in healthy subjects.

Authors:  E Lunell; K E Andersson; O Borgå; P O Fagerström; N Johannesson; G Kjellin; C G Persson; K Sjölund
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.